Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
RestDep
A Guided Internet-delivered Intervention for Adults With Residual Cognitive Symptoms After Major Depressive Disorder: Study Protocol for a Randomized Controlled Trial Investigating Clinical Effects
1 other identifier
interventional
44
1 country
1
Brief Summary
Background: Cognitive impairment and difficulties are frequently observed in individuals suffering from major depressive disorder. These impairments and difficulties can persist into remission as residual cognitive symptoms. Consequently affecting daily life functioning and quality of life for those affected. Few scalable interventions have targeted these symptoms and measured long-term clinical effects such as depression relapse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2021
CompletedStudy Start
First participant enrolled
April 26, 2021
CompletedFirst Posted
Study publicly available on registry
April 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedMarch 12, 2025
March 1, 2025
2.5 years
April 21, 2021
March 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Behaviour Rating Inventory Of Executive Function-Adult
The Behavior Rating Inventory of Executive Function-Adult (BRIEF-A; Roth, Isquith, \& Gioia, 2005) is a 75-item self-report questionnaire designed to measure adults' behaviors associated with executive problems.
2.5 years
Perceived Deficit Questionnaire 5
Brief assessment of subjective cognitive difficulties and covers problems with concentration (e.g. "trouble concentrating on things like watching a television program or reading a book?"), memory (e.g. "forget what you talked about after a telephone conversation?"), and executive functioning (e.g. "have trouble getting things organized?"). Every item is rated on a scale of 0 (Never) to 4 (Almost always) to yield a sum score of 0 to 20, with higher scores indicating greater severity of cognitive symptoms.
2.5 years
Secondary Outcomes (8)
Rumination Response Scale
2.5 years
Montgomery Aasberg Depression Rating Scale
2.5 years
Patient Health Questionaire 9 and 2
2.5 years
The Satisfaction With Life Scale
2.5 years
The Credibility/Expectancy Questionnaire
8 months
- +3 more secondary outcomes
Study Arms (2)
Experimental: Intervention
EXPERIMENTALParticipants will after baseline receive a guided intervention with weekly therapist support.
Control: Waitlist
NO INTERVENTIONParticipants will not receive intervention until 7 weeks after baseline.
Interventions
The intervention is fully digital with weekly telephone guidance. Key intervention elements are 1) psychoeducation, 2) attention training, 3) strategy training. Cognitive domains as attention, memory and executive functions are covered and rumination.
Eligibility Criteria
You may qualify if:
- Previously received treatment for major depressive disorder in primary or secondary healthcare services
- Reporting a history of major depressive disorder symptoms assess using the MINI. few or minor depression symptomss (\< 12 MADRS)
- Not meeting criteria for major depressive disorder measured by the MINI)
- Self-reporting residual cognitive symptoms that affects daily functioning (assessed by clinical psychologist)
- No changes in anti-depressant medication under the study period
- Age between 18 and 65 years
- Read and write Norwegian
- Internet and telephone access.
You may not qualify if:
- Self-reported substance abuse
- Neurological conditions or damage (e.g. autism, cerebral haemorrhage, and brain tumour)
- Bipolar disorder
- Psychosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Haukeland University Hospitallead
- University of Bergencollaborator
Study Sites (1)
Haukeland University Hospital
Bergen, Norway
Related Publications (1)
Myklebost SB, Heltne A, Hammar A, Nordgreen T. Efficacy of an internet-delivered cognitive enhancement intervention for subjective residual cognitive deficits in remitted major depressive disorder: A randomized crossover trial. J Affect Disord. 2024 Nov 1;364:87-95. doi: 10.1016/j.jad.2024.08.035. Epub 2024 Aug 12.
PMID: 39142571RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tine Nordgreen, PhD
Projectleader
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The assessor do not allocate the participant to the intervention or waitlist group.
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2021
First Posted
April 28, 2021
Study Start
April 26, 2021
Primary Completion
October 31, 2023
Study Completion
April 30, 2024
Last Updated
March 12, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share